Technology
Health
Pharmaceutical
Anika Therapeutics
$29.709876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$29.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.16 (0.54%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell ANIK and other stocks, options, ETFs, and crypto commission-free!
About
Anika Therapeutics Inc. Common Stock, also called Anika Therapeutics, is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Read More Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company was founded in 1992 and is headquartered in Bedford, MA.
Employees
133
Headquarters
Bedford, Massachusetts
Founded
1992
Market Cap
419.76M
Price-Earnings Ratio
23.07
Dividend Yield
0.00
Average Volume
166.52K
High Today
$29.97
Low Today
$29.31
Open Price
$29.72
Volume
43.10K
52 Week High
$51.22
52 Week Low
$28.54
Collections
Technology
Health
Pharmaceutical
Therapy
US
North America
News
MarketBeatMar 8
Stock Price, News, & Analysis for Anika Therapeutics
Anika Therapeutics, Inc., together with its subsidiaries, provides orthopedic medicines for patients with degenerative orthopedic diseases and traumatic conditions in the United States and internationally. The company develops, manufactures, and commercializes therapeutic products based on its proprietary hyaluronic acid (HA) technology. Its orthobiologics products comprise ORTHOVISC, ORTHOVISC mini, MONOVISC, and CINGAL for the treatment of osteoarthritis of the knee; HYALOFAST, a biodegradable support for...
Simply Wall StMar 2
Those Who Purchased Anika Therapeutics Shares A Year Ago Have A 37% Loss To Show For It
Investors can approximate the average market return by buying an index fund. But if you buy individual stocks, you can do both better or worse than that. For example, the Anika Therapeutics, Inc. (NASDAQ:ANIK) share price is down 37% in the last year. That contrasts poorly with the market return of 5.0%. However, the longer term returns haven’t been so bad, with the stock down 28% in the last three years. On top of that, the share price has dropped a further 14% in a month. Importantly, this could be a mark...
TradingNewsNowFeb 27
Stock to Track: Anika Therapeutics (NASDAQ: ANIK)
Anika Therapeutics is in the biotechnology industry and is part of the healthcare sector. The company CEO is Joseph G. Darling. Anika Therapeutics Inc develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. Previous Intraday Trading Performance: The ANIK stock showed a previous change of 2.03% with an open at 32.27 and a close of 33.19. It reached an intraday high of 33.86 and a low of 32.27. SeekingAlpha: Anika Therapeutics Inc. (ANIK) CEO Joseph Darling...
Price Paid on Robinhood
16% Lower
Right Now
52 Week Low
$28.54
Average Price Paid
$35.37
52 Week High
$51.22
Earnings
-$0.46
-$0.05
$0.35
$0.76
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
—
Actual
Expected May 1, After Hours